Fuji Pharma Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3816200004
JPY
1,729.00
3 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
12,859.00
11,095.00
13,000.00
12,983.00
11,767.00
10,642.00
10,746.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,859.00
11,095.00
13,000.00
12,983.00
11,767.00
10,642.00
10,746.00
Raw Material Cost
7,997.00
6,510.00
7,785.00
7,737.00
7,573.00
6,045.00
7,276.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
95.00
66.00
76.00
59.00
54.00
43.00
40.00
Selling and Distribution Expenses
3,054.00
2,915.00
3,216.00
2,681.00
2,648.00
2,424.00
2,472.00
Other Expenses
65.20
55.20
66.90
84.20
72.00
54.60
109.70
Total Expenditure (Excl Depreciation)
11,798.00
10,043.00
11,746.00
11,319.00
10,995.00
9,058.00
10,885.00
Operating Profit (PBDIT) excl Other Income
1061
1052
1254
1664
772
1584
-139
Other Income
-24.00
34.00
48.00
4.00
52.00
73.00
3,117.00
Operating Profit (PBDIT)
2,003.00
2,065.00
2,313.00
2,654.00
1,805.00
2,526.00
3,822.00
Interest
95.00
66.00
76.00
59.00
54.00
43.00
40.00
Exceptional Items
6.00
-640.00
147.00
-155.00
22.00
559.00
919.00
Gross Profit (PBDT)
4,862.00
4,585.00
5,215.00
5,246.00
4,194.00
4,597.00
3,470.00
Depreciation
966.00
979.00
1,011.00
986.00
981.00
869.00
844.00
Profit Before Tax
948.00
379.00
1,372.00
1,457.00
792.00
2,171.00
3,856.00
Tax
404.00
83.00
381.00
219.00
139.00
654.00
1,116.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
543.00
296.00
991.00
1,237.00
653.00
1,518.00
2,739.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
543.00
296.00
991.00
1,237.00
653.00
1,518.00
2,739.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
543.00
296.00
991.00
1,237.00
653.00
1,518.00
2,739.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
45,524.00
45,731.00
47,756.00
45,560.00
44,957.00
44,063.00
41,980.00
Earnings per share (EPS)
22.23
12.12
40.74
50.84
26.86
62.44
112.69
Diluted Earnings per share
22.23
12.12
40.74
50.84
26.86
62.44
112.69
Operating Profit Margin (Excl OI)
8.25%
9.48%
9.65%
12.82%
6.56%
14.88%
-1.29%
Gross Profit Margin
14.88%
12.24%
18.33%
18.82%
15.07%
28.57%
43.74%
PAT Margin
4.22%
2.67%
7.62%
9.53%
5.55%
14.26%
25.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 15.90% vs -14.65% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 83.45% vs -70.13% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -0.20% vs -10.33% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 43.94% vs -13.16% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Fuji Pharma Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
12,859.00
14,034.00
-1,175.00
-8.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,859.00
14,034.00
-1,175.00
-8.37%
Raw Material Cost
7,997.00
11,772.00
-3,775.00
-32.07%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
95.00
38.00
57.00
150.00%
Selling and Distribution Expenses
3,054.00
1,510.00
1,544.00
102.25%
Other Expenses
65.20
-3.80
69.00
1,815.79%
Total Expenditure (Excl Depreciation)
11,798.00
13,282.00
-1,484.00
-11.17%
Operating Profit (PBDIT) excl Other Income
1,061.00
752.00
309.00
41.09%
Other Income
-24.00
-1.00
-23.00
-2,300.00%
Operating Profit (PBDIT)
2,003.00
1,875.00
128.00
6.83%
Interest
95.00
38.00
57.00
150.00%
Exceptional Items
6.00
-164.00
170.00
103.66%
Gross Profit (PBDT)
4,862.00
2,262.00
2,600.00
114.94%
Depreciation
966.00
1,124.00
-158.00
-14.06%
Profit Before Tax
948.00
549.00
399.00
72.68%
Tax
404.00
-127.00
531.00
418.11%
Provisions and contingencies
0
0
0.00
Profit After Tax
543.00
691.00
-148.00
-21.42%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
543.00
691.00
-148.00
-21.42%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-16.00
16.00
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
543.00
675.00
-132.00
-19.56%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
45,524.00
52,003.00
-6,479.00
-12.46%
Earnings per share (EPS)
22.23
22.87
-0.64
-2.80%
Diluted Earnings per share
22.23
22.87
-0.64
-2.80%
Operating Profit Margin (Excl OI)
8.25%
5.36%
0.00
2.89%
Gross Profit Margin
14.88%
11.92%
0.00
2.96%
PAT Margin
4.22%
4.92%
0.00
-0.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,285.90 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.90% vs -14.65% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 9.28% vs 14.72% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 54.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 83.45% vs -70.13% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -16.85% vs 210.95% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 202.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -0.20% vs -10.33% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 15.63% vs 28.99% in Jun 2024

Quarterly - Interest
Interest 9.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 43.94% vs -13.16% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 75.93% vs 100.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.25%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024